will be first in vivo HSC-directed therapy tested in humans Preclinical data to be presented at ASH Annual Meeting demonstrate proof-of-concept for efficient in vivo engineering of HSCs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback